{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:56:29Z","timestamp":1777694189695,"version":"3.51.4"},"reference-count":65,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"DOI":"10.1210\/jc.2010-0898","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T13:05:36Z","timestamp":1299330336000},"page":"580-588","source":"Crossref","is-referenced-by-count":54,"title":["Approach to the Pediatric Patient with Graves' Disease: When Is Definitive Therapy Warranted?"],"prefix":"10.1210","volume":"96","author":[{"given":"Andrew J.","family":"Bauer","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology, Department of Pediatrics, Walter Reed Army Medical Center, Washington, D.C. 20307; Uniformed Services University, Bethesda, Maryland 20814; and The Thyroid Center, Division of Endocrinology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113392993400_B1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0889-8529(05)70302-9","article-title":"Thyrotoxicosis in children.","volume":"27","author":"Zimmerman","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key\n\t\t\t\t2019041113392993400_B2","first-page":"745","article-title":"Evaluation of diagnosis and treatment results in children with Graves' disease with emphasis on the pubertal status of patients.","volume":"21","author":"Poyrazo\u00f0lu","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B3","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1210\/jcem.85.10.6922","article-title":"Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients.","volume":"85","author":"Lazar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/thy.1997.7.755","article-title":"Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy.","volume":"7","author":"Shulman","year":"1997","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113392993400_B5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.1999.9.871","article-title":"Special features of Graves' disease in early childhood.","volume":"9","author":"Segni","year":"1999","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113392993400_B6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s004310051202","article-title":"Growth in childhood thyrotoxicosis.","volume":"158","author":"Wong","year":"1999","journal-title":"Eur J Pediatr"},{"key":"key\n\t\t\t\t2019041113392993400_B7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.0.1300565","article-title":"Incidence of juvenile thyrotoxicosis in Denmark, 1982\u20131988. A nationwide study.","volume":"130","author":"Lavard","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B8","doi-asserted-by":"crossref","first-page":"132041","DOI":"10.1186\/1687-9856-2009-132041","article-title":"Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use.","volume":"2009","author":"Rivkees","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B9","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1210\/jc.2008-0842","article-title":"Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment.","volume":"93","author":"Kaguelidou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF03346552","article-title":"Graves' disease prevalence in a young population with Turner syndrome.","volume":"33","author":"Wasniewska","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113392993400_B11","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1016\/j.jaci.2009.09.053","article-title":"Immunologic endocrine disorders.","volume":"125","author":"Michels","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key\n\t\t\t\t2019041113392993400_B12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/EJE-09-0751","article-title":"Peculiarities of Graves' disease in children and adolescents with Down's syndrome.","volume":"162","author":"De Luca","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.2003.035980","article-title":"Juvenile thyrotoxicosis; can we do better?","volume":"89","author":"Birrell","year":"2004","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t2019041113392993400_B14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/jc.2005-0686","article-title":"A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease.","volume":"91","author":"Taylor","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B15","first-page":"310","article-title":"Graves' disease in childhood: advances in management with antithyroid drug therapy.","volume":"71","author":"Kaguelidou","year":"2009","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113392993400_B16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ncpendmet0886","article-title":"Techniques to quantify TSH receptor antibodies.","volume":"4","author":"Ajjan","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113392993400_B18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF03346315","article-title":"Clinical and endocrine features and long-term outcome of Graves' disease in early childhood.","volume":"30","author":"Bossowski","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113392993400_B19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2265.2005.02415.x","article-title":"Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study.","volume":"64","author":"Cassio","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113392993400_B20","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1542\/peds.2007-1535","article-title":"Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.","volume":"121","author":"Glaser","year":"2008","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113392993400_B21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2004.10.070","article-title":"Hashitoxicosis in children: clinical features and natural history.","volume":"146","author":"Nabhan","year":"2005","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041113392993400_B22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1430727","article-title":"Thyroid ultrasound compared with World Health Organization 1960 and 1994 palpation criteria for determination of goiter prevalence in regions of mild and severe iodine deficiency.","volume":"143","author":"Zimmermann","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00595-005-3115-3","article-title":"Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy.","volume":"36","author":"Cappelli","year":"2006","journal-title":"Surg Today"},{"key":"key\n\t\t\t\t2019041113392993400_B24","first-page":"2805","article-title":"Outcome of differentiated thyroid cancer in Graves' patients.","volume":"83","author":"Pellegriti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-07-0136","article-title":"Recent outcome of Graves' disease patients with papillary thyroid cancer.","volume":"157","author":"Yano","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B26","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/mpo.1330","article-title":"Thyroid carcinoma in a fourteen-year-old boy with Graves disease.","volume":"38","author":"Niedziela","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"key\n\t\t\t\t2019041113392993400_B27","article-title":"63 years and 715 days to the \u201cboxed warning\u201d: unmasking of the propylthiouracil problem","author":"Rivkees","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs.","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113392993400_B29","first-page":"CD003420","article-title":"Antithyroid drug regimen for treating Graves' hyperthyroidism.","volume":"1","author":"Abraham","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041113392993400_B30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bmj.39114.670150.BE","article-title":"Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.","volume":"334","author":"Walter","year":"2007","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113392993400_B31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02295","article-title":"Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-3476(77)80843-3","article-title":"Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents.","volume":"91","author":"Barnes","year":"1977","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019041113392993400_B33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/08035250500252872","article-title":"Graves' disease in children and adolescents: response to long-term treatment.","volume":"94","author":"Barrio","year":"2005","journal-title":"Acta Paediatr"},{"key":"key\n\t\t\t\t2019041113392993400_B34","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archpedi.1987.04460100062026","article-title":"Remission in children with hyperthyroidism treated with propylthiouracil. Long-term results.","volume":"141","author":"Gorton","year":"1987","journal-title":"Am J Dis Child"},{"key":"key\n\t\t\t\t2019041113392993400_B35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","article-title":"Management of hyperthyroidism in children and adolescents.","volume":"60","author":"Hamburger","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/08035259950168405","article-title":"Thyrotoxicosis in children: thirty years' experience.","volume":"88","author":"Raza","year":"1999","journal-title":"Acta Paediatr"},{"key":"key\n\t\t\t\t2019041113392993400_B37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1542\/peds.54.5.565","article-title":"Twenty-two years' experience in the medical management of juvenile thyrotoxicosis.","volume":"54","author":"Vaidya","year":"1974","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113392993400_B38","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1210\/jcem-64-6-1241","article-title":"Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.","volume":"64","author":"Lippe","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B39","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1210\/jc.2008-0660","article-title":"Clinical and economic outcomes of thyroid and parathyroid surgery in children.","volume":"93","author":"Sosa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B41","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2007-0229","article-title":"Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease.","volume":"92","author":"Erbil","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/thy.2006.16.259","article-title":"The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy.","volume":"16","author":"McLeod","year":"2006","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113392993400_B43","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/J357LMD66E9X2505","article-title":"Postresection parathyroid hormone and parathyroid hormone decline accurately predict hypocalcemia after thyroidectomy.","volume":"127","author":"Al\u00eda","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2019041113392993400_B44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archotol.130.1.63","article-title":"The role of intraoperative rapid parathyroid hormone monitoring for predicting thyroidectomy-related hypocalcemia.","volume":"130","author":"Higgins","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key\n\t\t\t\t2019041113392993400_B45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.otohns.2009.08.026","article-title":"The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia.","volume":"141","author":"Sabour","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key\n\t\t\t\t2019041113392993400_B46","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.2003-031223","article-title":"A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients.","volume":"89","author":"Read","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJM197601012940123","article-title":"Letter: Follow-up of children treated with 131-I.","volume":"294","author":"Safa","year":"1976","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113392993400_B48","first-page":"3767","article-title":"Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment.","volume":"83","author":"Rivkees","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B49","first-page":"9","article-title":"Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis.","volume":"81","author":"Nikiforov","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B50","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/jnci\/dji129","article-title":"Risk of thyroid cancer after exposure to 131I in childhood.","volume":"97","author":"Cardis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t2019041113392993400_B51","first-page":"173","article-title":"Graves' ophthalmopathy (GO), are the extrathyroidal manifestations of Graves' disease. Foreword.","volume":"7","author":"Krassas","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"key\n\t\t\t\t2019041113392993400_B52","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/thy.2010.1640","article-title":"The tale of radioiodine and Graves' orbitopathy.","volume":"20","author":"Ponto","year":"2010","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113392993400_B53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/bjo.86.7.740","article-title":"Ophthalmopathy in childhood Graves' disease.","volume":"86","author":"Chan","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t2019041113392993400_B54","first-page":"146","article-title":"Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease.","volume":"105","author":"Acuna","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key\n\t\t\t\t2019041113392993400_B55","first-page":"234","article-title":"Pediatric aspects in Graves' orbitopathy.","volume":"7","author":"Gogakos","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"key\n\t\t\t\t2019041113392993400_B56","volume-title":"Pediatric pathology","author":"Stocker","year":"1992","edition":"1st ed"},{"key":"key\n\t\t\t\t2019041113392993400_B57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1542\/peds.111.4.745","article-title":"Influence of iodine-131 dose on the outcome of hyperthyroidism in children.","volume":"111","author":"Rivkees","year":"2003","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113392993400_B58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3413\/nukmed-0087","article-title":"Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?","volume":"47","author":"Kobe","year":"2008","journal-title":"Nuklearmedizin"},{"key":"key\n\t\t\t\t2019041113392993400_B59","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/jc.2008-2700","article-title":"Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.","volume":"94","author":"Noh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113392993400_B60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semarthrit.2006.03.003","article-title":"Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management.","volume":"36","author":"Aloush","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t2019041113392993400_B61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2230.1995.tb01340.x","article-title":"ANCA-associated vasculitis and lupus-like syndrome caused by methimazole.","volume":"20","author":"Kawachi","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"key\n\t\t\t\t2019041113392993400_B62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4158\/EP09304.CR","article-title":"Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with Graves' disease: cross-reaction between propylthiouracil and methimazole.","volume":"16","author":"Ahmed","year":"2010","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041113392993400_B63","doi-asserted-by":"crossref","first-page":"176970","DOI":"10.1186\/1687-9856-2010-176970","article-title":"Adverse events associated with methimazole therapy of Graves' disease in children.","volume":"2010","author":"Rivkees","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"key\n\t\t\t\t2019041113392993400_B64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1507\/endocrj.52.505","article-title":"Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.","volume":"52","author":"Shibayama","year":"2005","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t2019041113392993400_B65","first-page":"1719","article-title":"Predictors of early remission of hyperthyroidism in children.","volume":"82","author":"Glaser","year":"1997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/96\/3\/580\/9066779\/jcem0580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T14:23:38Z","timestamp":1685975018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/96\/3\/580\/2596398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0898","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}